Venture Capital

QuatRx Pharmaceuticals Co., a pharmaceutical firm in Ann Arbor, Michigan, that licensed some of University of Wisconsin-Madison professor Hector DeLuca's technology in 2002, has filed for an IPO. ...

Mithridion, the University of Wisconsin-Madison spinoff developing a drug for people with Alzheimer's disease, has closed its first round of financing with $1.6 million that will go toward buying lab equipment, hiring scientists and developing drug candidates....